References
- Singh M, Kaur M, Silakari O. Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem 2014;84:206–39
- Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005;26:343–56
- Detsi A, Majdalani M, Kontogiorgis CA, et al. Natural and synthetic 2′-hydroxy-chalcones and aurones: Synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity. Bioorg Med Chem 2009;17:8073–85
- Lewin G, Aubert G, Thoret S, et al. Influence of the skeleton on the cytotoxicity of flavonoids. Bioorg Med Chem 2012;20:1231–9
- Fan R, Ban SR, Feng X, et al. Synthesis and anti-VSMC vegetation activities of new aurone derivatives. Chem Res Chinese Universities 2012;28:438–42
- Venkateswarlu S, Panchagnula GK, Gottumukkala AD, Subbaraju GV. Synthesis, structural revision, and biological activities of 40-chloroaurone, a metabolite of marine brown alga Spatoglossum variabile. Tetrahedron 2007;63:6909–14
- Mcalpine JB, Chu W-l A, Ratnayake S, et al. Antimicrobial aurone derivatives. WO 1997026873 A1, 1997
- Kumar R, Dubey RK, Dixit P, Arya S. Naturally occurring aurones and chromones- potential organic therapeutic agents improvising nutritional security. Int J Innov Res Sci Eng Technol 2014;3:8141–8
- Kayser O, Kiderlen AF. Leishmanicidal activity of aurones. Tokai J Exp Clin Med 1999;23:423–6
- Kayser O, Chen M, Kharazmi A, Kiderlen AFZ. Aurones interfere with Leishmania major mitochondrial fumarate reductase. Naturforsch 2002;57:717–20
- Roussaki M, Lima SC, Kypreou AM, et al. Aurones: a promising heterocyclic scaffold for the development of potent antileishmanial agents. Int J Med Chem 2012;2012:1–8
- Wang J, Wang N, Yao X, Kitanaka S. Structures and anti-histamine activity of chalcones & aurones compounds from Bidens parviflora Willd. Asian J Trad Med 2007;2:23–9
- Bandgar BP, Patil SA, Korbad BL, et al. Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents. Eur Med Chem 2010;45:3223–7
- Jardosh H, Patel MP. Antimicrobial and antioxidant evaluation of new quinolone based aurone analogs. Arabian J Chem 2014. (in press)
- Morimoto M, Fukumoto H, Nozoe T, et al. Synthesis and insect antifeedant activity of aurones against spodoptera litura larvae. J Agric Food Chem 2007;55:700–5
- Zhang M, Xu XH, Cui Y, et al. Synthesis and herbicidal potential of substituted aurones. Pest Manag Sci 2012;68:1512–22
- Gao X, Yang L, Shu L, et al. Aurone constituents from the flowers of rosa rugosa and their biological activities. Heterocycles 2012;85:1925–31
- Gao X-M, Yang L-Y, Huang X-Z, et al. Aurones and isoaurones from the flowers of rosa damascena and their biological activities. Heterocycles 2013;87:583–9
- Meguellati A, Ahmed Belkacem A, Yi W, et al. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Eur Med Chem 2014;80:579–92
- Haudecoeur R, Ahmed Belkacem A, Yi W, et al. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. J Med Chem 2011;54:5395–402
- Gupta AK, Singh P, Sabarwal N. Rationalization of molecular descriptors of aurone analogs toward antimalarial activity. Asian J Pharm Clin Res 2014;7:186–92
- Carrasco MP, Newton AS, Gonçalves L, et al. Probing the aurone scaffold against Plasmodium falciparum: design, synthesis and antimalarial activity. Eur J Med Chem 2014;80:523–34
- Di Giovanni S, Borloz A, Urbain A, et al. In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods. Eur J Pharm Sci 2008;33:109–19
- Sheng R, Xu Y, Hu C, et al. Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives. Eur J Med Chem 2009;44:7–17
- Geldenhuys WJ, Funk MO, Van der Schyf CJ, Carroll RT. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors. Bioorg Med Chem Lett 2012;22:1380–3
- Nenadis N, Sigalas MP. A DFT study on the radical scavenging activity of maritimetin and related aurones. J Phys Chem 2008;112:12196–202
- Shin SY, Shin MC, Shin JS, et al. Synthesis of aurones and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells. Bioorg Med Chem Lett 2011;21:4520–3
- Lee YR, Hwang JK, Koh HW, et al. Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice. Life Sci 2012;90:799–807
- Huang W, Liu MZ, Li Y, et al. Design, synthesis, and antitumor activity of novel chromone and aurone derivatives. Bioorg Med Chem 2007;15:5191–7
- Schoepfer J, Fretz H, Chaudhuri B, et al. Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics. J Med Chem 2002;25:1741–7
- Boumendjel A. Aurones: a subclass of flavones with promising biological potential. Curr Med Chem 2003;10:2621–30
- Dubois C, Haudecoeur R, Orio M, et al. Versatile effects of aurone structure on mushroom tyrosinase activity. Chem Bio Chem 2012;13:559–65
- Parate A, Sharma R, Maheshwari I. Structural indents for 5-hydroxyaurone derivatives as potent anticancer agents against HUVEC cancer cell lines-kNN MFA approach. Der Pharmacia Sinica 2013;4:121–9
- Zwergel C, Valente S, Salvato A, et al. Novel benzofuran–chromone and –coumarin derivatives: synthesis and biological activity in K562 human leukemia cells. Med Chem Commun 2013;4:1571–9
- Cheng H, Zhang L, Liu Y, et al. The total design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines. Eur J Med Chem 2010;45:5950–7
- Okombi S, Rival D, Bonnet S, et al. Discovery of benzylidenebenzofuran-3(2h)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes. J Med Chem 2006;49:329–33
- Lawrence NJ, Rennison D, McGown AT, Hadfield JA. The total synthesis of an aurone isolated from uvaria hamiltonii: aurones and flavones as anticancer agents. Bioorg Med Chem Lett 2003;13:3759–63
- Zheng X, Wang H, Liu YM, et al. Synthesis, characterization, and anticancer effect of trifluoromethylated aurone derivatives. J Heterocyclic Chem 2014. (in press)
- Ballinari D, Bonomini L, Ermoli A, et al. Chem. Abst. CA2441274A1. WO2002083123 A1, 2002
- Pratt WB, Ruddon RW, Ensminger WD. The anticancer drugs. New York: Oxford University Press; 1994:69–198
- Rajski SC, Williams RM. DNA cross-linking agents as antitumor drugs. Chem Rev 1998;98:2723–96
- Demirayak S, Yurttaş L. Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives. J Enzyme Inhib Med Chem 2014. (in press)
- Gundogdu Karaburun N, Karaburun AC, Demirayak S, et al. Synthesis and anticancer activity of some 2-[3/4-(2-substituted phenyl-2-oxoethoxy)benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one derivatives. Lett Drug Des Discov 2014;11:578–85
- Sousa CM, Berthet J, Delbaere S, Coelho PJ. One pot synthesis of aryl substituted aurones. Dyes Pigments 2011;92:537–41
- Thakkar K, Cushman M. A novel oxidative cyclization of 2'-hydroxychalcones to 4,5-dialkoxyaurones by thallium(III) nitrate. J Org Chem 1995;60:6499--6510
- Bose AK, Manhas MS, Ghosh M, et al. Microwave-induced organic reaction enhancement chemistry. 2. Simplified techniques. J Org Chem 1991;56:6968–70
- Higginbotham L, Stephen H. Coumaraone Series. I. The preparation of 4-, 5- and 6-methylcoumaran-2-ones and some derivate of o-, m- and p-tolyloxyacetic acids. J Am Chem Soc 1920;117:1534–42
- Balakrishna KJ, Rao NP, Seshadri TR. A method of distinguishing between flavones and flavonols. Proc Indian Natl Sci Acad A 1949;29A:394–403
- Geissman TA, Harborne JB. Anthochlor pigments. XIII. The ultraviolet absorption spectra of phenolic plant pigments. polyhydroxyaurones. J Am Chem Soc 1956;78:832–7
- Dean FM, Podimuang V. The course of the Algar-Flynn-Oyamada (A.F.O.) reaction. J. Chem Soc 1965:3978–87
- Goldsack RJ, Shannon JS. Proximity effects in the electron impact mass spectra of aurones and related compounds. Org Mass Spectrometr 1980;15:545–55
- Boyd MR. Status of the NCI preclinical antitumor drug discovery screen, principles and practice of oncology. Princip Prac Oncol 1989;3:1–42
- Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 1995;34:91–109